Insider Selling: Organigram Holdings Inc. (TSE:OGI) Senior Officer Sells 12,014 Shares of Stock

Organigram Holdings Inc. (TSE:OGI - Get Free Report) Senior Officer Paolo De Luca sold 12,014 shares of the business's stock in a transaction on Thursday, October 24th. The shares were sold at an average price of C$2.52, for a total transaction of C$30,275.28.

Paolo De Luca also recently made the following trade(s):

• On Wednesday, September 11th, Paolo De Luca sold 13,835 shares of Organigram stock. The stock was sold at an average price of C$2.54, for a total value of C$35,140.90.
• On Friday, August 16th, Paolo De Luca sold 10,266 shares of Organigram stock. The shares were sold at an average price of C$2.76, for a total value of C$28,334.16.

Organigram Stock Down 1.2 %

Shares of OGI stock traded down C$0.03 during trading hours on Tuesday, hitting C$2.55. 448,910 shares of the company's stock traded hands, compared to its average volume of 303,204. The company has a quick ratio of 2.62, a current ratio of 6.95 and a debt-to-equity ratio of 1.13. The stock's fifty day simple moving average is C$2.47 and its two-hundred day simple moving average is C$2.40. Organigram Holdings Inc. has a 12-month low of C$1.36 and a 12-month high of C$3.95. The stock has a market cap of C$276.85 million, a price-to-earnings ratio of -1.02, a PEG ratio of 0.42 and a beta of 1.13.

Organigram (TSE:OGI - Get Free Report) last announced its quarterly earnings data on Tuesday, August 13th. The company reported C$0.03 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of C($0.07) by C$0.10. Organigram had a negative return on equity of 54.53% and a negative net margin of 153.80%. The business had revenue of C$41.06 million during the quarter, compared to analysts' expectations of C$39.20 million. On average, analysts expect that Organigram Holdings Inc. will post 0.1632373 EPS for the current year.

Wall Street Analysts Forecast Growth

Separately, Canaccord Genuity Group raised their price objective on Organigram from C$3.25 to C$3.60 and gave the company a "speculative buy" rating in a research report on Wednesday, August 14th.

About Organigram

Organigram Holdings Inc, through its subsidiaries, engages in the production and sale of cannabis and cannabis-derived products in Canada. It offers medical cannabis products, including whole flower, milled flower, pre-rolls, infused pre-rolls, vapes, gummies, and concentrates for medical retailers; adult use recreational cannabis under the SHRED, Holy Mountain, Big Bag O' Buds, Monjour, Trailblazer, SHRED'ems, Edison Cannabis Co, Edison JOLTS, Tremblant, and Laurentian brands.